GlassScriptPhysician profile
Arlen Richard
NPI 1245693894
$4,416.93
in general payments reported to CMS, 2019-2025
11 companies · $982 in 2025
The $982 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $485 · 2020: $20.49 · 2021: $834 · 2022: $616 · 2023: $799 · 2024: $680 · 2025: $982.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,461.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,909.83 | 2020-2025 | Clareon, Hydrus Microstent, Argos |
| Ivantis, INC | $512.35 | 2021 | |
| Allergan, INC. | $286.46 | 2019 | |
| New World Medical,INC. | $198.68 | 2019 | |
| Bausch & Lomb Americas INC. | $117.31 | 2022 | |
| Biotissue Holdings INC. | $103.29 | 2025 | |
| Sight Sciences, INC. | $67.14 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Abbvie INC. | $66.29 | 2022-2025 | |
| Aerie Pharmaceuticals, INC. | $58.98 | 2021 | |
| Glaukos Corporation | $56.87 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $39.73 | 2024 | Tecnis Iol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arlen Richard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.